Literature DB >> 20682666

Musculoskeletal complications of hereditary hemochromatosis: a case-control study.

Pascal Richette1, Sébastien Ottaviani, Eric Vicaut, Thomas Bardin.   

Abstract

OBJECTIVE: Arthropathy that mimics osteoarthritis (OA) and osteoporosis (OP) is considered a classic complication of hereditary hemochromatosis (HH) but has never been investigated in a cross-sectional study. We investigated whether HH is associated with increased prevalence of OA and OP and related factors.
METHODS: A self-administered questionnaire was completed by 306 patients with HH and 304 age and sex-matched unaffected controls.
RESULTS: The mean age of patients was 60.1 ± 11.3 years, and 47.4% were women. More patients with HH than controls had been given a diagnosis of OA: 50.5% vs 28.9% [adjusted OR (aOR) 2.5, 95% CI 1.8-3.6]. Compared with controls, patients with HH had a higher risk of knee (aOR 5.3, 95% CI 1.1-25.6) and hip replacement prosthesis (aOR 5.2, 95% CI 2.2-11.9). More patients than controls had been diagnosed with OP: 23.3% vs 4.6% (aOR 7.3, 95% CI 3.2-17.0). Patients with HH showed an increased prevalence, although not significant, of wrist (aOR 1.7, 95% CI 0.9-3.0) or vertebral fractures (aOR 1.7, 95% CI 0.8-3.8). The severity of iron overload, as defined by a ferritin level > 1000 μg/l at diagnosis, was associated with OA (p = 0.0005), OP (p = 0.01), presence of hip prosthesis (p = 0.04), wrist fractures (p = 0.002), and vertebral fractures (p = 0.02).
CONCLUSION: This case-control study strongly suggests a significant association among HH, OA, and OP. Joint involvement can be severe, especially in patients with substantially elevated ferritin levels.

Entities:  

Mesh:

Year:  2010        PMID: 20682666     DOI: 10.3899/jrheum.100234

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Iron homeostasis in osteoporosis and its clinical implications.

Authors:  G F Li; Y Z Pan; P Sirois; K Li; Y J Xu
Journal:  Osteoporos Int       Date:  2012-04-14       Impact factor: 4.507

2.  Systemic administration of a pharmacologic iron chelator reduces cartilage lesion development in the Dunkin-Hartley model of primary osteoarthritis.

Authors:  Lindsey H Burton; Maryam F Afzali; Lauren B Radakovich; Margaret A Campbell; Lauren A Culver; Christine S Olver; Kelly S Santangelo
Journal:  Free Radic Biol Med       Date:  2021-12-16       Impact factor: 7.376

Review 3.  [Approach to joint effusion].

Authors:  M Henniger; S Rehart
Journal:  Orthopade       Date:  2016-09       Impact factor: 1.087

Review 4.  HFE-related hemochromatosis: an update for the rheumatologist.

Authors:  Emma Husar-Memmer; Andreas Stadlmayr; Christian Datz; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

5.  Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis.

Authors:  António Camacho; Thomas Funck-Brentano; Márcio Simão; Leonor Cancela; Sébastien Ottaviani; Martine Cohen-Solal; Pascal Richette
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 6.  Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.

Authors:  Viktória Jeney
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

7.  Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients.

Authors:  Chi-Duc Nguyen; Vincent Morel; Adeline Pierache; Georges Lion; Bernard Cortet; René-Marc Flipo; Valérie Canva-Delcambre; Julien Paccou
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-07-16       Impact factor: 5.346

Review 8.  Treatment of nongout joint deposition diseases: an update.

Authors:  Tristan Pascart; Pascal Richette; René-Marc Flipo
Journal:  Arthritis       Date:  2014-05-08

Review 9.  Influence of Iron on Bone Homeostasis.

Authors:  Enikő Balogh; György Paragh; Viktória Jeney
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18

10.  Development and formulation of the classification criteria for osteoarthritis.

Authors:  Cibo Huang; Zhiyi Zhang; Yaolong Chen; Yue Zhang; Dan Xing; Like Zhao; Jianhao Lin; Yifang Mei; Hsiao-Yi Lin; Yi Zheng; Wei-Chung Tsai; Shengyun Liu; Quan Jiang; Yi Liu; Jinwei Chen; Zhizhong Ye; Min Chen; Yingjuan Chen; Cong-Qiu Chu; Ming Gao; Lan He; Jin Lin; Lijun Wu; Jianhua Xu; Pinting Yang; Xuewu Zhang; Qing Jiang; Guanghua Lei; Mengtao Li; Wanling Yang; Xin Gu; Yixin Zhou; Dongyi He; Wei Liu; Weiya Zhang; Changhai Ding; Xiaofeng Zeng
Journal:  Ann Transl Med       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.